Artificial Intelligence
The Global Fetal Monitoring Devices Market to Register Immense Growth at CAGR of ~7% by 2027 | DelveInsight
New York, USA, Jan. 17, 2023 (GLOBE NEWSWIRE) — The Global Fetal Monitoring Devices Market to Register Immense Growth at CAGR of ~7% by 2027 | DelveInsight
The global fetal monitoring device market is anticipated to grow positively owing to the increased need for monitoring fetuses for various congenital disabilities and the prevalence of preterm births and post-term pregnancy, the development of technologically advanced fetal monitors, the growing adoption of minimally invasive procedures, and the rise in government and non-government initiatives for maternal and fetal health around the world.
DelveInsight’s Fetal Monitoring Devices Market Insights report provides the current and forecast market analysis, individual leading Fetal Monitoring Devices companies’ market shares, challenges, fetal monitoring devices market drivers, barriers, and trends, and key fetal monitoring devices companies in the market.
Key Takeaways from the Fetal Monitoring Devices Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global fetal monitoring devices market during the forecast period.
- Notable fetal monitoring devices companies such as Koninklijke Philips N.V., General Electric Company, Cardinal Health, Nidek Medical, Siemens Healthcare GmbH, Heal Force, Medgyn Products, Inc., Promed Technology Co., Limited, Shenzhen Comen Medical Instruments Co., Ltd., Narang Medical Limited, Trivitron Healthcare, Neoventa Medical AB, Huntleigh Healthcare Ltd, EDAN Instruments, Inc., Shenzhen Bestman Instrument Co., Ltd., Natus Medical Incorporated, CooperSurgical Inc., Contec Medical Systems Co., Ltd, Life Plus Healthcare (P) Ltd., Bionet, and several others are currently operating in the fetal monitoring devices market.
- In March 2022, Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, received a USD 5 million grant from the Bill and Melinda Gates Foundation to improve maternal and fetal health. With this grant, Butterfly will provide 1,000 healthcare workers in Sub-Saharan Africa with the Butterfly iQ+, the world’s only handheld, whole-body point-of-care ultrasound probe.
- In February 2022, CooperSurgical set to acquire Cook Medical’s Reproductive Health Division to expand its offerings of ob-gyn and fertility medical devices.
- In June 2021, Remote pregnancy monitoring company Nuvo Group announced the FDA supplemental 510(k) clearance to add a new uterine activity module to its INVU system. INVU is a physician-prescribed, wearable pregnancy monitoring system.
To read more about the latest highlights related to the fetal monitoring devices market, get a snapshot of the key highlights entailed in the Global Fetal Monitoring Devices Market Report
Fetal Monitoring Devices Overview
A fetal monitoring device is a medical device that includes a monitoring unit, cables, and electrodes. They are intended to measure, record, and display fetal heart rate, uterine contractions, and maternal blood pressure, as well as heart rate, before and during childbirth. It is a medical method used to check the health of an unborn baby to ensure a safe birth. Furthermore, it tracks chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision and hearing problems, and jaundice.
Fetal Monitoring Devices Market Insights
North America is expected to account for the largest share of the global fetal monitoring devices market out of all regions. Factors such as the increasing prevalence of various fetal birth defects and an increase in preterm births are expected to aid in the growth of the North American fetal monitoring devices Market. Furthermore, the country’s government is actively involved in maternal and fetal health initiatives throughout the country. According to the CDC 2022, several state-based birth defects programs currently track CHDs in newborns and young children. As a result of the rising prevalence of these defects in the country, there will be greater demand for treatments that use fetal monitoring devices, creating a favorable growth environment for the United States fetal monitoring devices market and the North American region.
To know more about why North America is leading the market growth in the fetal monitoring devices market, get a snapshot of the Fetal Monitoring Devices Market Outlook
Fetal Monitoring Devices Market Dynamics
The fetal monitoring devices market is experiencing increased product demand for a variety of reasons. The primary driver of product demand is an increased need to monitor fetuses for various birth defects. Furthermore, the prevalence of preterm births, post-term pregnancy, the development of technologically advanced fetal monitors, the growing adoption of minimally invasive procedures, and the increase in government and non-government initiatives for maternal and fetal health across the world are anticipated to bolster the fetal monitoring devices market growth.
However, the risks associated with invasive fetal monitoring and the high equipment cost may be some of the factors limiting the growth of the fetal monitoring devices market.
Additionally, the fetal monitoring devices market witnessed a COVID-19 outbreak, which significantly increased the use of fetal monitoring devices. People who had COVID-19 during their pregnancy were at an increased risk of complications affecting their pregnancy and developing babies. COVID-19, for example, increases the risk of having a preterm (before 37 weeks) or stillborn baby. This resulted in an increase in demand for fetal monitoring devices during the pandemic. Furthermore, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemically made the resumption of regular healthcare services, which will keep demand for these products on track in the fetal monitoring devices market.
Get a sneak peek at the fetal monitoring devices market dynamics @ Fetal Monitoring Devices Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2019–2027 |
| Base Year | 2021 |
| Fetal Monitoring Devices Market CAGR | ~7% |
| Projected Fetal Monitoring Devices Market Size by 2027 | USD 4.72 Billion |
| Key Fetal Monitoring Devices Companies | Koninklijke Philips N.V., General Electric Company, Cardinal Health, Nidek Medical, Siemens Healthcare GmbH, Heal Force, Medgyn Products, Inc., Promed Technology Co., Limited, Shenzhen Comen Medical Instruments Co., Ltd., Narang Medical Limited, Trivitron Healthcare, Neoventa Medical AB, Huntleigh Healthcare Ltd, EDAN Instruments, Inc., Shenzhen Bestman Instrument Co., Ltd., Natus Medical Incorporated, CooperSurgical Inc., Contec Medical Systems Co., Ltd, Life Plus Healthcare (P) Ltd., Bionet, among others |
Fetal Monitoring Devices Market Assessment
- Fetal Monitoring Devices Market Segmentation
- Market Segmentation By Product: Ultrasound Devices (2D Ultrasound, 3D & 4D Ultrasound), Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Telemetry Devices, Others
- Market Segmentation By Method: Invasive, Non-Invasive,
- Market Segmentation By Portability: Portable, Non-Portable
- Market Segmentation By End User: Hospitals, Obstetrics & Gynecology Clinics, Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the fetal monitoring devices market are set to emerge as the trendsetter explore @ Fetal Monitoring Devices Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Fetal Monitoring Devices Market |
| 7 | Fetal Monitoring Devices Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Fetal Monitoring Devices Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the fetal monitoring devices market by 2027? Click to get a snapshot of the Fetal Monitoring Devices Market Trends
Related Reports
Fetal and Neonatal Monitoring Devices Market
Fetal and Neonatal Monitoring Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key fetal and neonatal monitoring devices companies, including GE Healthcare, Medtronic, Siemens Healthcare, among others.
Beating Heart Stabilizers Market
Beating Heart Stabilizers Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key beating heart stabilizers companies, including Medtronic, Getinge AB, Terumo Cardiovascular Systems Inc, Chase Medical, among others.
Congestive Heart Failure (CHF) Treatment Devices Market
Congestive Heart Failure (CHF) Treatment Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key congestive heart failure (CHF) treatment devices companies, including General Electric Company, Boston Scientific Corporation, Medtronic, among others.
Prosthetic Heart Valve Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key prosthetic heart valve companies, including Medtronic, Boston Scientific Corporation, St, Jude Medical, among others.
Tissue Heart Valves Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key tissue heart valves companies, including Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, Medtronic, among others.
Other Trending Reports
Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Uncategorized7 days agoArm CEO Rene Haas will be delivering a Partner’s Event Speech at COMPUTEX 2024
-
Artificial Intelligence6 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Uncategorized7 days ago
BJEI: A New Record of High Performance in 2023 and a New Pattern of Diversified and Coordinated Development
-
Uncategorized7 days ago
Integrity Food Marketing Joins Forces with CA Ferolie to Expand East Coast Reach from Maine to Florida
-
Uncategorized7 days ago
Dimethyl Carbonate Market worth $1.9 billion by 2028 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence6 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence7 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Artificial Intelligence7 days agoXinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation
